Skip to main content
RARE logo

RARE · Ultragenyx Pharmaceutical Inc. · Short Interest

Track RARE — free
$16.08 +0.43 (+2.75%) At close · Oct 26
Market Cap
$1.54B
Shares
98.59M
Volume · Oct 26 3.02M Avg daily vol (3M) 4.12M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

RARE Latest Reported Short Interest

FINRA reported 20,145,283 RARE shares sold short as of the October 15, 2026 settlement date, a decrease of 204,594 shares. Days to cover was 5.18 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

RARE Short Interest Forecast

Equibles' model estimates 20,064,911 shares sold short for the October 30, 2026 settlement, -0.4% versus the latest reported position, with a likely range of 18,283,528 to 22,136,653 shares. This model prediction uses FINRA data through October 26, 2026; FINRA's official release is expected November 10, 2026.

Model estimate

Expected Oct 30 short interest

as of Oct 26 Low confidence 51% chance it rises
20,064,911 -0.4% vs reported
Likely range 18,283,528 to 22,136,653 The latest estimate appears in the chart below. Official release expected Nov 10. Methodology
Short Squeeze Score
66/100
Short interest 20.4% of shares — P98 Days to cover 5.2 — P68 Price vs VWAP -7.9% — P44 Short-volume trend -8.7% — P21 Short interest change -1.0% — P45 Worst FTD 0.16% of shares — P88

Positioning score 65.8 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-27 00:54 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-11-13 Scheduled
FINRA publishes Nov 24
— — — —
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 20,145,283 20,349,877 -204,594 5.18
2026-09-30 20,349,877 16,571,956 +3,777,921 3.13
2026-09-15 16,571,956 17,144,354 -572,398 2.22
2026-08-31 17,144,354 15,887,767 +1,256,587 8.00
2026-08-14 15,887,767 14,963,396 +924,371 7.78
2026-07-31 14,963,396 13,435,087 +1,528,309 8.28
2026-07-15 13,435,087 16,217,153 -2,782,066 6.94
2026-06-30 16,217,153 14,312,759 +1,904,394 3.60
2026-06-15 14,312,759 14,703,432 -390,673 8.85
2026-05-29 14,703,432 13,976,318 +727,114 9.83
2026-05-15 13,976,318 13,665,812 +310,506 8.22
2026-04-30 13,665,812 12,088,495 +1,577,317 8.40
2026-04-15 12,088,495 11,413,679 +674,816 7.09
2026-03-31 11,413,679 9,932,072 +1,481,607 4.81
2026-03-13 9,932,072 9,597,141 +334,931 4.78
2026-02-27 9,597,141 9,861,470 -264,329 5.40
2026-02-13 9,861,470 9,095,903 +765,567 3.92
2026-01-30 9,095,903 8,861,656 +234,247 3.85
2026-01-15 8,861,656 8,017,399 +844,257 2.72
2025-12-31 8,017,399 8,600,577 -583,178 1.88
2025-12-15 8,600,577 8,871,538 -270,961 5.66
2025-11-28 8,871,538 7,828,953 +1,042,585 7.17
2025-11-14 7,828,953 7,144,800 +684,153 5.33
2025-10-31 7,144,800 8,692,947 -1,548,147 5.63

Full FINRA short interest reporting calendar

Showing 1–24 of 24 settlements
Key facts CIK 1515673 CUSIP 90400D108 13F (30d) 26 filings 26 filers Visit website Investor relations